Stock screener

BDX

Conviction 57HealthcareScan · Tue, Sep 8, 2026
BDX$179.22-2.99%
ResistanceSupportVol 14Insider sellCongress buyCongress sell
63 bars
Vol MA14 1.65M
Jun 9Jun 26Jul 16Aug 3Aug 20Sep 8
BECTON DICKINSON & COSURGICAL & MEDICAL INSTRUMENTS & APPARATUSwww.bd.com
Price179.22
Change-2.99%
Gap-1.80%
Rel volume0.90×
Avg volume1.61M
Avg $ vol300.78M
SMA 20186.16
SMA 50170.47
SMA 200171.65
Price vs 50+5.13%
Price vs 200+4.41%
MA stackmixed
50/200 cross
Supertrendup · 178.34
RSI (14)47
MACD hist-1.83
MACD crossbear · 7d
Stoch %K / %D4 / 31
ADX (14)45
+DI / −DI24 / 21
RSI divergence
MACD divergenceBearish
ATR %+2.38%
ADR %2.09%
52w high210.02
52w low140.71
From 52w high-14.67%
Above 52w low+27.37%
New 52w highNo
SqueezeOff
Bollinger width7.79%
%B0.02
Donchian pos13.11%
Donchian high193.07
Donchian low177.13
AVWAP (52w high)161.45
vs AVWAP high+11.00%
AVWAP (52w low)165.81
vs AVWAP low+8.08%
OBV trendFlat
Chaikin MF (20)0.02
Today vs 20d0.90×
Avg vol (14d)1.65M
Avg vol (20d)1.61M
Avg $ vol (20d)300.78M
Market cap48.82B
RS 3m (vs SPY)+17.79%
RS 6m (vs SPY)-4.00%
RS line new highNo
Trend template5/8
Technical rank57.2
1 week-4.73%
1 month+1.33%
3 months+19.49%
6 months+8.32%
1 year-6.85%
YTD-8.06%
P/E29.09
P/B2.00
P/S2.24
P/FCF12.56
EPS5.82
Div yield2.45%
ROE6.87%
ROA3.31%
Debt/Eq0.58
Current0.87
EV/EBITDA12.37
Gross margin34.69%
Net margin7.68%
Rev growth8.24%
EPS growth-1.58%
Price target193.30
Target upside7.86%
Analyst ratingBuy
Institutional110.82%
Ent. value62.37B
Revenue4.98B
Net income377M
Gross profit
Free cash flow3.89B
IndustrySURGICAL & MEDICAL INSTRUMENTS & APPARATUS
ExchangeNYSE
Shares out275.54M
Employees72K
ListedWed, Sep 25, 1963
Free float283.77M
Float %99.7%
Short interest9.37M
Days to cover4.8d
Short volume63.0%
Squeeze score46 / 100
Next earnings
EPS forecast
Last EPS vs est$3.23 vs $3.14
Last surprise+2.9% beat
Setup gradeC
Conviction57 / 100
Pattern quality
Tech rank57.2 / 100
Group rank96 / 100 · Leading
Status laneNo active setup
Setup direction
Pattern family
Resistance192.41
Support157.21
Days since event
Candle confirm
News sentiment

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in BDX · 10 recent

All disclosures →
MemberSideAmount
Alan Armstrong
Alan Armstrong
senate · R · OK · traded 2026-03-27
Buy$1K–$15K
Thomas H. Kean
Thomas H. Kean
house · R · NJ · traded 2026-05-21
Sell$1K–$15K
RK
Rohit Khanna
house · CA
Buy
Kevin Hern
Kevin Hern
house · OK · traded 2026-03-17
Sell$15K–$50K
Lisa McClain
Lisa McClain
house · R · MI · traded 2025-06-17
Buy$1K–$15K
Lisa McClain
Lisa McClain
house · R · MI · traded 2025-06-24
Sell$1K–$15K
Thomas H. Kean
Thomas H. Kean
house · R · NJ · traded 2025-05-13
Buy$1K–$15K
Rob Bresnahan
Rob Bresnahan
house · PA · traded 2025-05-15
Buy$1K–$15K
Rob Bresnahan
Rob Bresnahan
house · PA · traded 2025-04-08
Sell$1K–$15K
Jefferson Shreve
Jefferson Shreve
house · R · IN · traded 2025-03-05
Sell$15K–$50K

Insider activity

SEC Form 4 transactions in BDX · 3 buys · 7 sells

InsiderSideShares
Feld Michael
EVP, Chief Revenue Officer · Common Stock · 2026-08-26
Sell165
Feld Michael
EVP, Chief Revenue Officer · Common Stock · 2026-08-20
Tax1.05K
Polen Thomas E Jr
Chairman, CEO and President · Common Stock · 2026-08-13
Exercise43.28K
Polen Thomas E Jr
Chairman, CEO and President · Common Stock · 2026-08-13
Disposition39.13K
Polen Thomas E Jr
Chairman, CEO and President · Common Stock · 2026-08-13
Sell4.15K
Polen Thomas E Jr
Chairman, CEO and President · Stock Appreciation Rights · 2026-08-13
Exercise43.28K
Goette Roland
EVP and President, EMEA · Common Stock · 2026-08-11
Sell2.44K
Byington Carrie L
Director · Rights to Common Stock Under BD Deferred Compensation Plan · 2026-08-06
Grant94
Huffines Robert Luther
Director · Rights to Common Stock Under BD Deferred Compensation Plan · 2026-08-06
Grant189
Feld Michael
EVP, Chief Revenue Officer · Common Stock · 2026-07-27
Sell75

SEC filings

EDGAR filings in BDX · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.